A Prospective Exploratory Study Evaluating the Diagnostic Usefulness of 18F-mFBG PET Imaging in Pheochromocytoma
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Drug
Study Type: Observational
SUMMARY
The aim of this study is to evaluate the diagnostic performance and tumor burden of 18F-metafluorobenzylguanidine (18F-MFBG) positron emission tomography (PET) in patients with pheochromocytoma.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:
• Aged 30-80 years old, primary school or above, with a regular caregiver;
• Clinically diagnosed patients with pheochromocytoma;
• Can provide informed consent, can understand and comply with the study requirements.
Locations
Other Locations
China
The First Affiliated Hospital of Zhejiang University School of Medicine
RECRUITING
Hangzhou
The First Affiliated Hospital Zhejiang University School of Medicine
RECRUITING
Hangzhou
Contact Information
Primary
Peipei Wang, MD
wpp199411@163.com
86 18511395988
Time Frame
Start Date: 2023-05-01
Estimated Completion Date: 2026-12
Participants
Target number of participants: 80
Treatments
18F-MFBG PET/CT in Pheochromocytoma
Each patient receive a single intravenous injection of 18F-MFBG 5.55 MBq/kg and undergo PET/CT or PET/MR scan after 60 min post-injection.
Related Therapeutic Areas
Sponsors
Leads: First Affiliated Hospital of Zhejiang University